RxDoctor Payments Data

John Foster, MD

Family Medicine · Ronan, MTNPI 1588864979

Payments from drug & device makers

$671in general payments, 2019–2025

Across 37 payments — averaging $18.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vanda Pharmaceuticals Inc.$90
  • Astellas Pharma US Inc$80
  • Boehringer Ingelheim$56
  • AbbVie$48
  • Amgen$48
  • Exact Sciences$47
  • plus $302 from 13 others

What the payments were for

  • Food & beverage$671100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$671 in reported general payments places this provider in the 80th percentile of 426 family medicine providers in Montana.

See all family medicine providers in Montana

Medicare billing

Part B allowed, 2024
$13,407
Medicare patients
37
Services billed
161

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate50$35,014
EliquisApixaban36$24,746
JardianceEmpagliflozin34$23,073
OzempicSemaglutide17$15,685
CreonLipase/Protease/Amylase12$11,856
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog17$9,883
XareltoRivaroxaban13$9,041
Spiriva RespimatTiotropium Bromide17$8,525
Spiriva HandihalerTiotropium Bromide12$5,794
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$5,162
MyrbetriqMirabegron12$4,989
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog12$3,756
Fluticasone-SalmeterolFluticasone Propion/Salmeterol20$3,371
Lantus SolostarInsulin Glargine,hum.Rec.Anlog31$2,985
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate14$2,668

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$31$35,01450 claims
Boehringer IngelheimJardiance, Spiriva Respimat$56$31,59851 claims
PfizerEliquis$24$24,74636 claims
AbbVieCreon$48$11,85612 claims
Astellas Pharma US IncMyrbetriq$80$4,98912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 426 family medicine providers in Montana.

Other family medicine in Ronan

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →